Q-State Biosciences is a discovery technology and therapeutics company based in Cambridge, MA, that combines advanced human cellular models, unique measurement engineering and AI / machine learning into a proprietary platform that enables novel discovery of optimized genetically targeted medicines for epilepsy, pain, and other diseases of the CNS.

Cardiology Neurology Toxicity screening Drug discovery Drug efficacy screening Pathology modeling Optogenetic Electrophysiology Voltage Calcium signal Precision Medicine Machine Learning Genomics Drug Discovery Personalized Medicine Genetic Therapies Optical Electrophysiology Gene Editing Stem Cells Optogenetics Transcriptomics Human Models Therapeutic Design & Screening Rare Disease Neurodegenerative Disrupting Medicine Functional Genomics BioTech/Drugs Commercial Physical Research Biotechnology